Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer

Non-small cell lung cancer is the predominant type of lung cancer, resulting in high mortality worldwide. Digoxin, a cardiac glycoside, has recently been suggested to be a novel chemotherapeutic agent. Src is an oncogene that plays an important role in cancer progression and is therefore a potential...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2015-05, Vol.10 (5), p.e0123305-e0123305
Hauptverfasser: Lin, Sheng-Yi, Chang, Hsiu-Hui, Lai, Yi-Hua, Lin, Ching-Hsiung, Chen, Min-Hsuan, Chang, Gee-Chen, Tsai, Meng-Feng, Chen, Jeremy J W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!